The cholinergic signalling deficit in AD suggests that early degeneration of basal forebrain cholinergic neurons and cortical acetylcholine deficit correlates with cognitive impairment, explaining symptomatic benefit of acetylcholinesterase inhibitors; however, this hypothesis fails to explain the major neurodegeneration in AD [104,108,109]. This evidence concerns the gene ACHE and Alzheimer disease.